Background & Objective: Dependence on substance or addiction is a psychological disturbance. This is referred to as substance abuse in psychological classifications and is the second most common psychological disturbance. On the other hand depression is an instance of disturbance, which is observed among the victims of substance abuse. This study set out to evaluate the effectiveness of Cognitive-Behavior Therapy (CBT) of depression among patients with substance abuse.

 Methods: Using experimental method, 28 men and women (23-35 years, normal IQ) with substance abuse were randomly selected according to DSMIV criteria. These subjects had been under anti-addiction medication for two years, without adequate control, and were divided into two groups. The two groups received the following treatments for 6 weeks: 1- Cognitive Behavior Therapy. 2- No specific psychological treatment (control group). Two instruments were used to collect data namely Beck Depression Inventory (BDI) to evaluate depression and demographic forms to record the information.

 Results: The data were analyzed using repeated measurements including a pretest and two posttests. In pretest, according to scores of both groups from Beck test, there was a severe depression among the subjects. However in the second and third posttests these scores fell significantly. The intra-group and inter-group tests showed that these reduction in scores was related to the intra-group differences.

 Conclusions: CBT has had an important role in treatment of depression among patients with substance abuse. Psychological intervention was able to help them change their cognition by decreasing depression and enable them to have a more positive belief in controlling themselves against dependency. It seems that taking psychologically team-approach (both theoretically and practically) about control strategies and treatment of depression in patients with substance abuse can deeply improve their life style as well as their individual and social relations.

 Background & Objectives: Different types of diets and several chemical and herbal drugs are used for decreasing the fasting blood glucose, glycosylated hemoglobin and insulin resistance in type II diabetic patients. New herbal medicines including cinnamon have been considered for controlling diabetes. Since few reports have been presented in other countries and many studies have been done in animal models in laboratory condition, this study was aimed to investigate cinnamon supplementation effects on fasting blood glucose, glycosylated hemoglobin and insulin resistance among type II diabetic patients .

 Methods: In a clinical trial study, 60 male and female patients with type II diabetes mellitus (30 patients in control and 30 patients in treatment group) were selected in Tabriz city, during 1388. The intervention group received 1.5 g of cinnamon (as a capsule containing 500 mg powder, three times daily) for 60 days and control group received placebo. Blood samples obtained from patients to determine the levels of fasting blood glucose, the glycosylated hemoglobin and insulin, before and after cinnamon consumption. Insulin resistance was measured by HOMA score and data were expressed as Mean ± SD and analyzed statistically by Student t-test. p<0.05 was considered as significant .

 Results: After 60 days, the fasting blood glucose levels, the glycosylated hemoglobin and the insulin resistance decreased significantly in the intervention group compared to controls (p<0.05). There was no significant change in the fasting blood glucose levels, the glycosylated hemoglobin and the insulin resistance in the control group at the end of 60 days.

 Conclusion: This study showed the consumption of cinnamon can be useful in the fasting blood glucose, the glycosylated hemoglobin and the insulin resistance control among type II diabetic patients .